Oncologists Receive More EHR Messages Than Other HCPs but Spend Less Time in EHRs
A new study suggests that electronic health records could be better tailored to meet the specific needs of oncologists.
Diagnosis & Disease Information
In Situ and Invasive Melanoma Diagnoses Decreased From 2019 to 2020
Diagnoses of in situ and invasive melanoma were stable from 2018 to 2019 but decreased from 2019 to 2020, researchers found.
Breakthroughs in Targeted Therapy, Immunotherapy Reduce Cancer Deaths
Breakthroughs in targeted therapy and immunotherapy are partly responsible for the recent decline in US cancer deaths, according to the AACR Cancer Progress Report 2023.
Global Incidence of Early-Onset Cancers Rose 80% From 1990 to 2019
New data suggest that, from 1990 to 2019, the global incidence of early-onset cancer increased by nearly 80%, and the rate of early-onset cancer deaths increased by nearly 30%.
Cancer Patients With ICI-Induced Acute Pancreatitis May Require Imaging, Monitoring
Cancer patients with ICI-induced acute pancreatitis may require abdominal imaging for diagnosis and monitoring for exocrine pancreatic insufficiency.
Cancer Patients Have Higher Prevalence of Myocardial Infarction as Cause of Chest Pain
Patients with current or past cancer have a higher prevalence of acute myocardial infarction as the cause of chest pain than patients without cancer.
Cancer Patients More Likely to Die From Early Omicron Variants of SARS-CoV-2
Cancer patients were more likely to die from the BA.1 and BA.2 omicron variants of SARS-CoV-2 than from wild-type SARS-CoV-2, data suggest.
Billing for Patient Portal Messages Reduces Docs’ Workloads but May Increase Financial Toxicity for Cancer Patients
Cancer patients are increasingly messaging their oncology care teams through patient portals, but many health systems have started to bill for this messaging.
Administrative Tasks Required to Pay for Cancer Care May Prompt Nonadherence
The burden of administrative tasks required to pay for cancer care is associated with nonadherence to care, a new study suggests.
High-Risk Melanoma Patients More Likely to Receive Immunotherapy at End of Life
Metastatic melanoma patients at the highest risk of death are more likely than lower-risk patients to receive immunotherapy near the end of their life.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...